Pneumococcal vaccine - Aventis Pasteur
Alternative Names: Pneumococcal surface protein A DNA vaccine - Aventis Pasteur; Pneumococcal surface protein A vaccine - Aventis PasteurLatest Information Update: 08 Apr 2022
At a glance
- Originator Nonindustrial source; sanofi pasteur
- Developer Nonindustrial source; Sanofi
- Class Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pneumococcal infections